CNS-active drugs in aging population at high risk of cerebrovascular events: Evidence from preclinical and clinical studies

Neuroscience and Biobehavioral Reviews

Volumn 32, Issue 1, 2008, Pages 56-71

  Zhao, Chuan Sheng ^a,b   Hartikainen, Sirpa ^c   Schallert, Timothy ^d,e   Sivenius, Juhani ^f   Jolkkonen, Jukka ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b CHINA MEDICAL UNIVERSITY   (China)

^c Food and Health Research Centre   (Finland)

^d UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Aging; Cerebrovascular events; Cognitive functions; Functional recovery; Medication; Sensorimotor impairment

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; NEUROLEPTIC AGENT;

CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; CONVALESCENCE; HIGH RISK POPULATION; HUMAN; MENTAL DISEASE; NERVE CELL PLASTICITY; NEUROBIOLOGY; NEUROTRANSMISSION; PRIORITY JOURNAL; REVIEW; SENSORIMOTOR FUNCTION; STROKE;

ADAPTATION, PHYSIOLOGICAL; AGED; AGED, 80 AND OVER; AGING; ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM AGENTS; COGNITION DISORDERS; HUMANS; MOVEMENT DISORDERS; RECOVERY OF FUNCTION; STROKE;

EID: 36348975127     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2007.05.003     Document Type: Review

References (197)

1. Anderson K.J., Scheff S.W., and DeKosky S.T. Reactive synaptogenesis in hippocampal area CA1 of aged and young adult rats. Journal of Computational Neurology 252 (1986) 374-384
2. Arboix A., Garcia-Eroles L., Comes E., Oliveres M., Balcells M., Pacheco G., and Targa C. Predicting spontaneous early neurological recovery after acute ischemic stroke. European Journal of Neurology 10 (2003) 429-435
3. Aronowski J., Strong R., Shirzadi A., and Grotta J.C. Ethanol plus caffeine (caffeinol) for treatment of ischemic stroke: preclinical experience. Stroke 34 (2003) 1246-1251
4. Ashtary F., Janghorbani M., Chitsaz A., Reisi M., and Bahrami A. A randomized, double-blind trial of bromocriptine efficacy in nonfluent aphasia after stroke. Neurology 66 (2006) 914-916
5. Badan I., Buchhold B., Hamm A., Gratz M., Walker L.C., Platt D., Kessler C., and Popa-Wagner A. Accelerated glial reactivity to stroke in aged rats correlates with reduced functional recovery. Journal of Cerebral Blood Flow and Metabolism 23 (2003) 845-854
6. Barat I., Andreasen F., and Damsgaard E.M. The consumption of drugs by 75-year-old individuals living in their own homes. European Journal of Clinical Pharmacology 56 (2000) 501-509
7. Barbui C., Percudani M., Fortino I., Tansella M., and Petrovich L. Past use of selective serotonin reuptake inhibitors and the risk of cerebrovascular events in the elderly. International Clinical Psychopharmacology 20 (2005) 169-171
8. Bavelier D., and Neville H.J. Cross-modal plasticity: where and how?. National Review in Neuroscience 3 (2002) 443-452
9. Berthier M.L., Pujol J., Gironell A., Kulisevsky J., Deus J., Hinojosa J., and Soriano-Mas C. Beneficial effect of donepezil on sensorimotor function after stroke. American Journal of Physical Medicine & Rehabilitation 82 (2003) 725-729
10. Biernaskie J., Chernenko G., and Corbett D. Efficacy of rehabilitative experience declines with time after focal ischemic brain injury. Journal of Neuroscience 24 (2004) 1245-1254
11. Blazer D., Hybels C., Simonsick E., and Hanlon J.T. Sedative, hypnotic, and antianxiety medication use in an aging cohort over ten years: a racial comparison. Journal of American Geriatrics Society 48 (2000) 1073-1079
12. Bowler J.V., Wade J.P., Jones B.E., Nijran K., Jewkes R.F., Cuming R., and Steiner T.J. Contribution of diaschisis to the clinical deficit in human cerebral infarction. Stroke 26 (1995) 1000-1006
13. Boyeson M.G., and Harmon R.L. Effects of trazodone and desipramine on motor recovery in brain-injured rats. American Journal of Physical Medicine & Rehabilitation 72 (1993) 286-293
14. Boyeson M.G., Harmon R.L., and Jones J.L. Comparative effects of fluoxetine, amitriptyline and serotonin on functional motor recovery after sensorimotor cortex injury. American Journal of Physical Medicine & Rehabilitation 73 (1994) 76-83
15. Butefisch C.M., Netz J., Wessling M., Seitz R.J., and Homberg V. Remote changes in cortical excitability after stroke. Brain 126 (2003) 470-481
16. Castren E. Neurotrophic effects of antidepressant drugs. Current Opinion in Pharmacology 4 (2004) 58-64
17. Centonze D., Gubellini P., Pisani A., Bernardi G., and Calabresi P. Dopamine, acetylcholine and nitric oxide systems interact to induce corticostriatal synaptic plasticity. Reviews in Neuroscience 14 (2003) 207-216
18. Chen R., Cohen L.G., and Hallett M. Nervous system reorganization following injury. Neuroscience 111 (2002) 761-773
19. Cicinelli P., Pasqualetti P., Zaccagnini M., Traversa R., Oliveri M., and Rossini P.M. Interhemispheric asymmetries of motor cortex excitability in the postacute stroke stage: a paired-pulse transcranial magnetic stimulation study. Stroke 34 (2003) 2653-2658
20. Cole M.G., Elie L.M., McCusker J., Bellavance F., and Mansour A. Feasibility and effectiveness of treatments for post-stroke depression in elderly inpatients: systematic review. Journal of Geriatrics Psychiatry and Neurology 14 (2001) 37-41
21. Conner J.M., Culberson A., Packowski C., Chiba A.A., and Tuszynski M.H. Lesions of the basal forebrain cholinergic system impair task acquisition and abolish cortical plasticity associated with motor skill learning. Neuron 38 (2003) 819-829
22. Conroy B., Zorowitz R., Horn S.D., Ryser D.K., Teraoka J., and Smout R.J. An exploration of central nervous system medication use and outcomes in stroke rehabilitation. Archives of Physiological Medicine and Rehabilitation 86 (2005) S73-S81
23. Cooper-Kuhn C.M., Winkler J., and Kuhn H.G. Decreased neurogenesis after cholinergic forebrain lesion in the adult rat. Journal of Neuroscience Research 77 (2004) 155-165
24. Craft T.K.S., Glasper E.R., McCullough L., Zhang N., Sugo N., Otsuka T., Hurn P.D., and DeVries A.C. Social interaction improves experimental stroke outcome. Stroke 36 (2005) 2006-2011
25. Creeley C., Wozniak D.F., Labruyere J., Taylor G.T., and Olney J.W. Low doses of memantine disrupt memory in adult rats. Journal of Neuroscience 26 (2006) 3923-3932
26. Crisostomo E.A., Duncan P.W., Propst M., Dawson D.V., and Davis J.N. Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Annals of Neurology 23 (1988) 94-97
27. Crocker A.D., and Hemsley K.M. An animal model of extrapyramidal side effects induced by antipsychotic drugs: relationship with D2 dopamine receptor occupancy. Progress in Neuropsychopharmacology Biological Psychiatry 25 (2001) 573-590
28. Cummings R.G., and Le Couteur D.G. Benzodiazepines and a risk of hip fractures in older people. a review of evidence. CNS Drugs 17 (2003) 825-837
29. Dam M., Tonin P., De Boni A., Pizzolato G., Casson S., Ermani M., Freo U., Piron L., and Battistin L. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 27 (1996) 1211-1214
30. Dancause N., Barbay S., Frost S.B., Plautz E.J., Chen D., Zoubina E.V., Stowe A.M., and Nudo R.J. Extensive cortical rewiring after brain injury. Journal of Neuroscience 25 (2005) 10167-10179
31. Darsalia V., Heldmann U., Lindvall O., and Kokaia Z. Stroke-induced neurogenesis in aged brain. Stroke 36 (2005) 1790-1795
32. De Ryck M., Duytschaever H., Pauwels P.J., and Janssen P.A. Ionic channels, cholinergic mechanisms, and recovery of sensorimotor function after neocortical infarcts in rats. Stroke 21 (1990) III158-III163
33. Dijkhuizen R.M., Singhal A.B., Mandeville J.B., Wu O., Halpern E.F., Finklestein S.P., Rosen B.R., and Lo E.H. Correlation between brain reorganization, ischemic damage, and neurologic status after transient focal cerebral ischemia in rats: a functional magnetic resonance imaging study. Journal of Neuroscience 23 (2003) 510-517
34. Ellul J., Archer N., Foy C.M.L., Poppe M., Boothby H., Nicholas, Brown H.R.G., and Lovestone S. The effects of commonly prescribed drugs in patients with Alzheimer's disease on the rate of deterioration. Journal of Neurology Neurosurgery and Psychiatry 78 (2007) 233-239
35. Elmstahl S., Stenberg I., Annerstedt L., and Ingvad B. Behavioral disturbances and pharmacological treatment of patients with dementia in family caregiving: a 2-year follow-up. International Psychogeriatrics 10 (1998) 239-252
36. Ensrud K.E., Blackwell T., Mangione C.M., Bowman P.J., Bauer D.C., Schwartz A., Hanlon J.T., Nevitt M.C., and Whooley M.A. Central nervous system active medications and risk for fractures in older women. Archives of Internal Medicine 163 (2003) 949-957
37. Eriksson M., Asplund K., Glader E.L., Norrving B., Stegmayr B., Terent A., Asberg K.H., and Wester P.O. Self-reported depression and use of antidepressants after stroke: a national survey. Stroke 35 (2004) 936-941
38. Erkinjuntti T., Roman G., Gauthier S., Feldman H., and Rockwood K. Emerging therapies for vascular dementia and vascular cognitive impairment. Stroke 35 (2004) 1010-1017
39. Everitt B.J., and Robbins T.W. Central cholinergic systems and cognition. Annual Reviews in Psychology 48 (1997) 649-684
40. Feeney D.M., and Sutton R.L. Pharmacotherapy for recovery of function after brain injury. Critic Review of Neurobiology 3 (1987) 135-197
41. Feeney D.M., Gonzalez A., and Law W.A. Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science 217 (1982) 855-857
42. Feeney D.M., De Smet A.M., and Rai S. Noradrenergic modulation of hemiplegia: facilitation and maintenance of recovery. Restorative Neurology and Neuroscience 22 (2004) 175-190
43. Fisher C.M. Concerning the mechanism of recovery in stroke hemiplegia. Canadian Journal of Neurological Science 19 (1992) 57-63
44. Floel A., Hummel F., Breitenstein C., Knecht S., and Cohen L.G. Dopaminergic effects on encoding of a motor memory in chronic stroke. Neurology 65 (2005) 472-474
45. Friel K.M., and Nudo R.J. Recovery of motor function after focal cortical injury in primates: compensatory movement patterns used during rehabilitative training. Somatosensory Motor Research 15 (1998) 173-189
46. Frost S.B., Barbay S., Friel K.M., Plautz E.J., and Nudo R.J. Reorganization of remote cortical regions after ischemic brain injury: a potential substrate for stroke recovery. Journal of Neurophysiology 89 (2003) 3205-3214
47. Gareri P., De Fazio P., De Fazio S., Marigliano N., Ferreri Ibbadu G., and De Sarro G. Adverse effects of atypical antipsychotics in the elderly: a review. Drugs and Aging 23 (2006) 937-956
48. Gemperle A.Y., Enz A., Pozza M.F., Luthi A., and Olpe H.R. Effects of clozapine, haloperidol and iloperidone on neurotransmission and synaptic plasticity in prefrontal cortex and their accumulation in brain tissue: an in vitro study. Neuroscience 117 (2003) 681-695
49. Gill S.S., Rochon P.A., Herrmann N., Lee P.E., Sykora K., Gunraj N., Normand S.L., Gurwitz J.H., Marras C., Wodchis W.P., and Mamdani M. Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study. British Medical Journal 330 (2005) 445
50. Goldstein L.B. Common drugs may influence motor recovery after stroke. The Sygen in Acute Stroke Study Investigators. Neurology 45 (1995) 865-871
51. Goldstein L.B. Potential effects of common drugs on stroke recovery. Archives of Neurology 55 (1998) 454-456
52. Goldstein L.B., and Bullman S. Differential effects of haloperidol and clozapine on motor recovery after sensorimotor cortex injury in rats. Neurorehabilitation and Neural Repair 16 (2002) 321-325
53. Grade C., Redford B., Chrostowski J., Toussaint L., and Blackwell B. Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study. Archives of Physical Medicine and Rehabilitation 79 (1998) 1047-1050
54. Halim N.D., Weickert C.S., McClintock B.W., Weinberger D.R., and Lipska B.K. Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus. Neuropsychopharmacology 29 (2004) 1063-1069
55. Hanlon C.A., Buffington A.L., and McKeown M.J. New brain networks are active after right MCA stroke when moving the ipsilesional arm. Neurology 64 (2005) 114-120
56. Harris J.F., and Eng J.J. Individuals with the dominant hand affected following stroke demonstrate less impairment than those with the nondominant hand affected. Neurorehabilitation Neural Repair 20 (2006) 380-389
57. Hartikainen S., and Klaukka T. Use of psychotropics is high among very old people. European Journal of Clinical Pharmacology 59 (2004) 849-850
58. Hartikainen S., Rahkonen T., Kautiainen H., and Sulkava R. Kuopio 75+ study: does advanced age predict more common use of psychotropics among the elderly?. International Clinical Psychopharmacology 18 (2003) 163-167
59. Hartikainen S., Rahkonen T., Kautiainen H., and Sulkava R. Use of psychotropics among home-dwelling nondemented and demented elderly. International Journal of Geriatric Psychiatry 18 (2003) 1135-1141
60. Hernandez T.D. Post-traumatic neural depression and neurobehavioral recovery after brain injury. Journal of Neurotrauma 23 (2006) 1211-1221
61. Hernandez T.D., and Holling L.C. Disruption of behavioral recovery by the anti-convulsant phenobarbital. Brain Research 635 (1994) 300-306
62. Hernandez T.D., and Schallert T. Seizures and recovery from experimental brain damage. Experimental Neurology 102 (1988) 318-324
63. Herrmann N., Mamdani M., and Lanctot K.L. Atypical antipsychotics and risk of cerebrovascular accidents. American Journal of Psychiatry 161 (2004) 1113-1115
64. Hsu J.E., and Jones T.A. Contralesional neural plasticity and functional changes in the less-affected forelimb after large and small cortical infarcts in rats. Experimental Neurology 201 (2006) 479-494
65. Huber R., Ghilardi M.F., Massimini M., Ferrarelli F., Riedner B.A., Peterson M.J., and Tononi G. Arm immobilization causes cortical plastic changes and locally decreases sleep slow wave activity. Nature Neuroscience 9 (2006) 1169-1176
66. Hughes S.G. Prescribing for the elderly patient: why do we need to exercise caution?. British Journal of Clinical Pharmacology 46 (1998) 531-533
67. Hummel F.C., and Cohen L.G. Non-invasive brain stimulation: a new strategy to improve neurorehabilitation after stroke?. Lancet Neurology 5 (2006) 708-712
68. Ingall T. Stroke-incidence, mortality, morbidity and risk. Journal of Insurance Medicine 36 (2004) 143-152
69. Jacobs K.M., and Donoghue J.P. Reshaping the cortical motor map by unmasking latent intracortical connections. Science 251 (1991) 944-947
70. Jiang W., Gu W., Brannstrom T., Rosqvist R., and Wester P. Cortical neurogenesis in adult rats after transient middle cerebral artery occlusion. Stroke 32 (2001) 1201-1207
71. Jin K., Minami M., Xie L., Sun Y., Mao X.O., Wang Y., Simon R.P., and Greenberg D.A. Ischemia-induced neurogenesis is preserved but reduced in the aged rodent brain. Aging Cell 3 (2004) 373-377
72. Jolkkonen J., Puurunen K., Rantakomi S., Sirvio J., Haapalinna A., and Sivenius J. Effects of fluoxetine on sensorimotor and spatial learning deficits following focal cerebral ischemia in rats. Restorative Neurology and Neuroscience 17 (2000) 211-216
73. Jones T.A., and Schallert T. Subcortical deterioration after cortical damage: effects of diazepam and relation to recovery of function. Behavioral Brain Research 51 (1992) 1-13
74. Jones T.A., and Schallert T. Use-dependent growth of pyramidal neurons after neocortical damage. Journal of Neuroscience 14 (1994) 2140-2152
75. Kallin K., Jensen J., Olsson L.L., Nyberg L., and Gustafson Y. Why the elderly fall in residential care facilities, and suggested remedies. Journal of Family Practice 53 (2004) 41-52
76. Karanian D.A., Baude A.S., Brown Q.B., Parsons C.G., and Bahr B.A. 3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism. Hippocampus 16 (2006) 834-842
77. Kauhanen M., Korpelainen J.T., Hiltunen P., Brusin E., Mononen H., Maatta R., Nieminen P., Sotaniemi K.A., and Myllyla V.V. Poststroke depression correlates with cognitive impairment and neurological deficits. Stroke 30 (1999) 1875-1880
78. Keilhoff G., Becker A., Grecksch G., Bernstein H.G., and Wolf G. Cell proliferation is influenced by bulbectomy and normalized by imipramine treatment in a region-specific manner. Neuropsychopharmacology 31 (2006) 1165-1176
79. Kimura M., Robinson R.G., and Kosier J.T. Treatment of cognitive impairment after poststroke depression: a double-blind treatment trial. Stroke 31 (2000) 1482-1486
80. Kelly-Hayes M. Stroke outcome measures. Journal of Cardiovascular Nursing 19 (2004) 301-307
81. Kippin T.E., Kapur S., and van der Kooy D. Dopamine specifically inhibits forebrain neural stem cell proliferation, suggesting a novel effect of antipsychotic drugs. Journal of Neuroscience 25 (2005) 5815-5823
82. Kleim J.A., Jones T.A., and Schallert T. Motor enrichment and the induction of plasticity before or after brain injury. Neurochemistry Research 28 (2003) 1757-1769
83. Kleim J.A., Chan S., Pringle E., Schallert K., Procaccio V., Jimenez R., and Cramer S.C. BDNF val66met polymorphism is associated with modified experience-dependent plasticity in human motor cortex. Nature Neuroscience 9 (2006) 735-737
84. Kolb B., Morshead C., Gonzalez C., Kim M., Gregg C., Shingo T., and Weiss S. Growth factor-stimulated generation of new cortical tissue and functional recovery after stroke damage to the motor cortex of rats. Journal of Cerebral Blood Flow and Metabolism 27 (2007) 983-997
85. Komitova M., Mattsson B., Johansson B.B., and Eriksson P.S. Enriched environment increases neural stem/progenitor cell proliferation and neurogenesis in the subventricular zone of stroke-lesioned adult rats. Stroke 36 (2005) 1278-1282
86. Kotani S., Yamauchi T., Teramoto T., and Ogura H. Pharmacological evidence of cholinergic involvement in adult hippocampal neurogenesis in rats. Neuroscience 142 (2006) 505-514
87. Kotila M., Numminen H., Waltimo O., and Kaste M. Post-stroke depression and functional recovery in a population-based stroke register. The Finnstroke study. European Journal of Neurology 6 (1999) 309-312
88. Kozlowski D., Jones T.A., and Schallert T. Pruning of dendrites and restoration after brain damage: role of the NMDA receptor. Restorative Neurology and Neuroscience 7 (1994) 119-126
89. Kozlowski D.A., Hilliard S., and Schallert T. Ethanol consumption following recovery from unilateral damage to the forelimb area of the sensorimotor cortex: reinstatement of deficits and prevention of dendritic pruning. Brain Research 763 (1997) 159-166
90. Kuhmonen J., Lukkarinen J., Grohn O., Jolkkonen J., and Sivenius J. Diazepam does not reduce infarct size in rats subjected to transient occlusion of the middle cerebral artery when normothermia is maintained. Journal of Pharmacy and Pharmacology 54 (2002) 1565-1569
91. Kwakkel G., Kollen B.J., van der Grond J., and Prevo A.J. Probability of regaining dexterity in the flaccid upper limb: impact of severity of paresis and time since onset in acute stroke. Stroke 34 (2003) 2181-2186
92. Kwakkel G., Kollen B., and Lindeman E. Understanding the pattern of functional recovery after stroke: facts and theories. Restorative Neurology and Neuroscience 22 (2004) 281-299
93. Laska A.C., von Arbin M., Kahan T., Hellblom A., and Murray V. Long-term antidepressant treatment with moclobemide for aphasia in acute stroke patients: a randomised, double-blind, placebo-controlled study. Cerebrovascular Disease 19 (2005) 125-132
94. Lasser R.A., and Sunderland T. Newer psychotropic medication use in nursing home residents. Journal of American Geriatrics Society 46 (1998) 202-207
95. Lawlor D.A., Patel R., and Ebrahim S. Association between falls in elderly women and chronic diseases and drug use: cross sectional study. British Medical Journal 327 (2003) 712-717
96. Lazar R.M., Fitzsimmons B.F., Marshall R.S., Berman M.F., Bustillo M.A., Young W.L., Mohr J.P., Shah J., and Robinson J.V. Reemergence of stroke deficits with midazolam challenge. Stroke 33 (2002) 283-285
97. Lazar R.M., Fitzsimmons B.F., Marshall R.S., Mohr J.P., and Berman M.F. Midazolam challenge re-induces neurological deficits after transient ischemic attack. Stroke 34 (2003) 794-796
98. Lee R.G., and van Donkelaar P. Mechanisms underlying functional recovery following stroke. Canadian Journal of Neurological Science 22 (1995) 257-263
99. Leker R.R., and Neufeld M.Y. Anti-epileptic drugs as possible neuroprotectants in cerebral ischemia. Brain Research and Brain Research Review 42 (2003) 187-203
100. Lichtenwalner R.J., and Parent J.M. Adult neurogenesis and the ischemic forebrain. Journal of Cerebral Blood Flow and Metabolism 26 (2006) 1-20
101. Liepert J., Storch P., Fritsch A., and Weiller C. Motor cortex disinhibition in acute stroke. Clinical Neurophysiology 111 (2000) 671-676
102. Lindner M.D., Gribkoff V.K., Donlan N.A., and Jones T.A. Long-lasting functional disabilities in middle-aged rats with small cerebral infarcts. Journal of Neuroscience 23 (2003) 10913-10922
103. Linjakumpu T., Hartikainen S., Klaukka T., Koponen H., Kivela S.L., and Isoaho R. Psychotropics among the home-dwelling elderly-increasing trends. International Journal of Geriatrics and Psychiatry 17 (2002) 874-883
104. Linjakumpu T., Hartikainen S., Klaukka T., Veijola J., Kivela S.L., and Isoaho R. Use of medications and polypharmacy are increasing among the elderly. Journal of Clinical Epidemiology 55 (2002) 809-817
105. Liu B., Anderson G., Mittmann N., To T., Axcell T., and Shear N. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 351 (1998) 1303-1307
106. Liu J., Solway K., Messing R.O., and Sharp F.R. Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils. Journal of Neuroscience 18 (1998) 7768-7778
107. Lodder J., van Raak L., Hilton A., Hardy E., and Kessels A. Diazepam to improve acute stroke outcome: results of the early GABA-ergic activation study in stroke trial. a randomized double-blind placebo-controlled trial. Cerebrovascular Disease 21 (2006) 120-127
108. Macdonald R.L., and Olsen R.W. GABAA receptor channels. Annual Review in Neuroscience 17 (1994) 569-602
109. Malberg J.E., Eisch A.J., Nestler E.J., and Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. Journal of Neuroscience 20 (2000) 9104-9110
110. Malberg J.E., and Schechter L.E. Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugs. Current Pharmaceutical Design 11 (2005) 145-155
111. Markus H.S. Current treatments in neurology: stroke. Journal of Neurology 252 (2005) 260-267
112. Markus T.M., Tsai S.Y., Bollnow M.R., Farrer R.G., O'Brien T.E., Kindler-Baumann D.R., Rausch M., Rudin M., Wiessner C., Mir A.K., Schwab M.E., and Kartje G.L. Recovery and brain reorganization after stroke in adult and aged rats. Annual Neurology 58 (2005) 950-953
113. Martinsson L., and Eksborg S. Drugs for stroke recovery: the example of amphetamines. Drugs and Aging 21 (2004) 67-79
114. Martinsson L., Wahlgren N.G., and Hardemark H.G. Amphetamines for improving recovery after stroke. Cochrane Database System Review (2003) CD002090
115. Matsumoto M., Togashi H., Ohashi S., Tachibana K., Yamaguchi T., and Yoshioka M. Serotonergic modulation of psychological stress-induced alteration in synaptic plasticity in the rat hippocampal CA1 field. Brain Research 1022 (2004) 221-225
116. Mattay V.S., Fera F., Tessitore A., Hariri A.R., Das S., Callicott J.H., and Weinberger D.R. Neurophysiological correlates of age-related changes in human motor function. Neurology 58 (2002) 630-635
117. Meltzer H.Y. What's atypical about atypical antipsychotic drugs?. Currunt Opinion in Pharmacology 4 (2004) 53-57
118. Mittmann T., Qu M., Zilles K., and Luhmann H.J. Long-term cellular dysfunction after focal cerebral ischemia: in vitro analyses. Neuroscience 85 (1998) 15-27
119. Nadeau S.E., Behrman A.L., Davis S.E., Reid K., Wu S.S., Stidham B.S., Helms K.M., and Gonzalez Rothi L.J. Donepezil as an adjuvant to constraint-induced therapy for upper-limb dysfunction after stroke: an exploratory randomized clinical trial. Journal of Rehabilitation Research and Development 41 (2004) 525-534
120. Nakayama H., Jorgensen H.S., Raaschou H.O., and Olsen T.S. Compensation in recovery of upper extremity function after stroke: the Copenhagen Stroke Study. Archives of Physical Medicine and Rehabilitation 75 (1994) 852-857
121. Nudo R.J., and Milliken G.W. Reorganization of movement representations in primary motor cortex following focal ischemic infarcts in adult squirrel monkeys. Journal of Neurophysiology 75 (1996) 2144-2149
122. Nudo R.J., Wise B.M., SiFuentes F., and Milliken G.W. Neural substrates for the effects of rehabilitative training on motor recovery after ischemic infarct. Science 272 (1996) 1791-1794
123. Ohashi S., Matsumoto M., Togashi H., Ueno K., and Yoshioka M. The serotonergic modulation of synaptic plasticity in the rat hippocampo-medial prefrontal cortex pathway. Neuroscience Letters 342 (2003) 179-182
124. Ohayon M.M., Caulet M., Priest R.G., and Guilleminault C. Psychotropic medication consumption patterns in the UK general population. Journal of Clinical Epidemiology 51 (1998) 273-283
125. Otani S., Daniel H., Roisin M.P., and Crepel F. Dopaminergic modulation of long-term synaptic plasticity in rat prefrontal neurons. Cerebral Cortex 13 (2003) 1251-1256
126. Paolucci S., Antonucci G., Grasso M.G., Morelli D., Troisi E., Coiro P., De Angelis D., Rizzi F., and Bragoni M. Post-stroke depression, antidepressant treatment and rehabilitation results. A case-control study. Cerebrovascular Disease 12 (2001) 264-271
127. Pariente J., Loubinoux I., Carel C., Albucher J.F., Leger A., Manelfe C., Rascol O., and Chollet F. Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Annual Neurology 50 (2001) 718-729
128. Percudani M., Barbui C., Fortino I., Tansella M., and Petrovich L. Second-generation antipsychotics and risk of cerebrovascular accidents in the elderly. Journal of Clinical Psychopharmacology 25 (2005) 468-470
129. Perera T.D., Coplan J.D., Lisanby S.H., Lipira C.M., Arif M., Carpio C., Spitzer G., Santarelli L., Scharf B., Hen R., Rosklija G., Sackeim H.A., and Dwork A.J. Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates. Journal of Neuroscience 27 (2007) 4894-4901
130. Pollock B.G. Psychotropic drugs and the aging patient. Geriatrics 53 (1998) S20-S24
131. Popa-Wagner A., Schroder E., Walker L.C., and Kessler C. beta-Amyloid precursor protein and ss-amyloid peptide immunoreactivity in the rat brain after middle cerebral artery occlusion: effect of age. Stroke 29 (1998) 2196-2202
132. Popa-Wagner A., Schroder E., Schmoll H., Walker L.C., and Kessler C. Upregulation of MAP1B and MAP2 in the rat brain after middle cerebral artery occlusion: effect of age. Journal of Cerebral Blood Flow and Metabolism 19 (1999) 425-434
133. Prakash N., Cohen-Cory S., Penschuck S., and Frostig R.D. Basal forebrain cholinergic system is involved in rapid nerve growth factor (NGF)-induced plasticity in the barrel cortex of adult rats. Journal of Neurophysiology 91 (2004) 424-437
134. Puurunen K., Jolkkonen J., Sirvio J., Haapalinna A., and Sivenius J. Selegiline combined with enriched-environment housing attenuates spatial learning deficits following focal cerebral ischemia in rats. Experimental Neurology 167 (2001) 348-355
135. Raedler T.J., Knable M.B., Jones D.W., Lafargue T., Urbina R.A., and Egan M.F. In vivo olanzapine occupancy of muscarinic acetylcholine receptors in patients with schizophrenia. Neuropsychopharmacology 23 (2000) 56-68
136. Ramasubbu R. Cerebrovascular effects of selective serotonin reuptake inhibitors: a systematic review. Journal of Clinical Psychiatry 65 (2004) 1642-1653
137. Rampello L., Battaglia G., Raffaele R., Vecchio I., and Alvano A. Is it safe to use antidepressants after a stroke?. Expert Opinion in Drug Safety 4 (2005) 885-897
138. Redecker C., Wang W., Fritschy J.M., and Witte O.W. Widespread and long-lasting alterations in GABA(A)-receptor subtypes after focal cortical infarcts in rats: mediation by NMDA-dependent processes. Journal of Cerebral Blood Flow and Metabolism. 22 (2002) 1463-1475
139. Ren M., Senatorov V.V., Chen R.-W., and Chuang D.-M. Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model. Proceedings of the National Academy Of Sciences of the United States of America 100 (2003) 6210-6215
140. Rossini P.M., and Dal Forno G. Neuronal post-stroke plasticity in the adult. Restorative Neurology and Neuroscience 22 (2004) 193-206
141. Rowntree S., and Kolb B. Blockade of basic fibroblast growth factor retards recovery from motor cortex injury in rats. European Journal of Neuroscience 9 (1997) 2432-2441
142. Ruths S., Straand J., and Nygaard H.A. Psychotropic drug use in nursing homes-diagnostic indications and variations between institutions. European Journal of Clinical Pharmacology 57 (2001) 523-528
143. Sairanen M., Lucas G., Ernfors P., Castren M., and Castren E. Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. Journal of Neuroscience 25 (2005) 1089-1094
144. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., Weisstaub N., Lee J., Duman R., Arancio O., Belzung C., and Hen R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301 (2003) 805-809
145. Sarter M. Preclinical research on cognition enhancers. Trends in Pharmacological Science 27 (2006) 602-608
146. Schallert T. Sensorimotor impairment and recovery of function in brain-damaged rats: Reappearance of symptoms during old age. Behavioral Neuroscience 97 (1983) 159-164
147. Schallert T. Aging-dependent emergence of sensorimotor dysfunction in rats recovered from dopamine depletion sustained early in life. In: Joseph J.A. (Ed). Central Determinants of Age-related Declines in Motor Function vol. 515 (1988), Annals of New York Academy of Sciences 108-120
148. Schallert T., and Hernandez T.D. GABAergic drugs and neuroplasticity after brain injury: impact on functional recovery. In: Goldstein L.B. (Ed). Restorative Neurology: Advances in Pharmacotherapy after Stroke (1998), Futura Publishing, Armonk, NY 91-120
149. Schallert T., and Lindner M.D. Rescuing neurons from trans-synaptic degeneration after brain damage: helpful, harmful, or neutral in recovery of function?. Canadian Journal of Psychology 44 (1990) 276-292
150. Schallert T., Overstreet D.H., and Yamamura H.I. Muscarinic receptor binding and behavioral effects of atropine following chronic catecholamine depletion or acetylcholinesterase inhibition in rats. Pharmacology Biochemistry and Behavior 13 (1980) 187-192
151. Schallert T., Hernandez T.D., and Barth T.M. Recovery of function after brain damage: severe and chronic disruption by diazepam. Brain Research 379 (1986) 104-111
152. Schallert T., Woodlee M.T., and Fleming S.M. Disentangling multiple types of recovery from brain injury. In: Krieglstein J., and Klumpp S. (Eds). Pharmacology of Cerebral Ischemia 2002 (2002), Medpharm Scientific Publishers, Stuttgart 201-216
153. Schallert T., Fleming S.M., and Woodlee M.T. Should the injured and intact hemispheres be treated differently during the early phases of physical restorative therapy in experimental stroke or parkinsonism?. Physiological Medicine and Rehabilitation Clinics in North America 14 (2003) S27-S46
154. Schauwecker P.E., Cheng H.W., Serquinia R.M., Mori N., and McNeill T.H. Lesion-induced sprouting of commissural/associational axons and induction of GAP-43 mRNA in hilar and CA3 pyramidal neurons in the hippocampus are diminished in aged rats. Journal of Neuroscience 15 (1995) 2462-2470
155. Scheidtmann K., Fries W., Muller F., and Koenig E. Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study. Lancet 358 (2001) 787-790
156. Schmanke T.D., Avery R.A., and Barth T.M. The effects of amphetamine on recovery of function after cortical damage in the rat depend on the behavioral requirements of the task. Journal of Neurotrauma 13 (1996) 293-307
157. Schroeder E., Vogelgesang S., Popa-Wagner A., and Kessler C. Neurofilament expression in the rat brain after cerebral infarction: effect of age. Neurobiological Aging 24 (2003) 135-145
158. Shapira S., Sapir M., Wengier A., Grauer E., and Kadar T. Aging has a complex effect on a rat model of ischemic stroke. Brain Research 925 (2002) 148-158
159. Shimizu T., Hosaki A., Hino T., Sato M., Komori T., Hirai S., and Rossini P.M. Motor cortical disinhibition in the unaffected hemisphere after unilateral cortical stroke. Brain 125 (2002) 1896-1907
160. Shirazi-Southall S., Rodriguez D.E., and Nomikos G.G. Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat. Neuropsychopharmacology 26 (2002) 583-594
161. Sivenius J., Sarasoja T., Aaltonen H., Heinonen E., Kilkku O., and Reinikainen K. Selegiline treatment facilitates recovery after stroke. Neurorehabilitation and Neural Repair 15 (2001) 183-190
162. Skangiel-Kramska J., Glazewski S., Jablonska B., Siucinska E., and Kossut M. Reduction of GABAA receptor binding and [3 H]muscimol in the barrel field of mice after peripheral denervation: transient and long-lasting effects. Experimental Brain Research 100 (1994) 39-46
163. Skoog I., Nilsson L., Landahl S., and Steen B. Mental disorders and the use of psychotropic drugs in an 85-year-old urban population. International Psychogeriatrics 5 (1993) 33-48
164. Sorensen L., Foldspang A., Gulmann N.C., and Munk-Jorgensen P. Determinants for the use of psychotropics among nursing home residents. International Journal of Geriatric Psychiatry 16 (2001) 147-154
165. Spirduso W.W., Schallert T., Erickson C., Fenton H.M., Fineg J., Knight G., Mayfield D., and Walters T. Ethanol and aging effects on movement initiation can be dissociated from general behavioral impairment using a high-speed lever-release task in rats. Alcohol and Drug Research 7 (1987) 259-271
166. Stranahan A.M., Khalil D., and Gould E. Social isolation delays the positive effects of running on adult neurogenesis. Nature Neuroscience 9 (2006) 526-533
167. Stroemer R.P., Kent T.A., and Hulsebosch C.E. Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with D-amphetamine therapy after neocortical infarction in rats. Stroke 29 (1998) 2381-2393 discussion 2393-2385
168. Thapa P.B., Gideon P., Cost T.W., Milam A.B., and Ray W.A. Antidepressants and the risk of falls among nursing home residents. New England Journal of Medicine 339 (1998) 875-882
169. Thored P., Arvidsson A., Cacci E., Ahlenius H., Kallur T., Darsalia V., Ekdahl C.T., Kokaia Z., and Lindvall O. Persistent production of neurons from adult brain stem cells during recovery after stroke. Stem Cells 24 (2006) 739-747
170. Traystman R.J., Klaus J.A., DeVries A.C., Shaivitz A.B., and Hurn P.D. Anticonvulsant lamotrigine administered on reperfusion fails to improve experimental stroke outcomes. Stroke 32 (2001) 783-787
171. Tune L., Carr S., Hoag E., and Cooper T. Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium. American Journal of Psychiatry 149 (1992) 1393-1394
172. Turkstra L.S., Holland A.L., and Bays G.A. The neuroscience of recovery and rehabilitation: what have we learned from animal research?. Archives Physiological Medicine and Rehabilitation 84 (2003) 604-612
173. Tzavara E.T., Bymaster F.P., and Nomikos G.G. The procholinergic effects of the atypical antipsychotic olanzapine are independent of muscarinic autoreceptor inhibition. Molecular Psychiatry 11 (2006) 619-621
174. Valla J., Humm J.L., Schallert T., and Gonzales-Lima F. Metabolic activity increases in the subependymal zone following cortical injury. NeuroReport 10 (1999) 2731-2734
175. Walker-Batson D., Smith P., Curtis S., Unwin H., and Greenlee R. Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further Evidence. Stroke 26 (1995) 2254-2259
176. Wang H.D., Dunnavant F.D., Jarman T., and Deutch A.Y. Effects of antipsychotic drugs on neurogenesis in the forebrain of the adult rat. Neuropsychopharmacology 29 (2004) 1230-1238
177. Ward N.S. Functional reorganization of the cerebral motor system after stroke. Current Opinion in Neurology 17 (2004) 725-730
178. Weiller C., Ramsay S.C., Wise R.J., Friston K.J., and Frackowiak R.S. Individual patterns of functional reorganization in the human cerebral cortex after capsular infarction. Annals of Neurology 33 (1993) 181-189
179. Weiner D.K., Hanlon J.T., and Studenski S.A. Effects of central nervous system polypharmacy on falls liability in community-dwelling elderly. Gerontology 44 (1998) 217-221
180. Wenk G.L. The nucleus basalis magnocellularis cholinergic system: one hundred years of progress. Neurobiology of Learning and Memory 67 (1997) 85-95
181. Whishaw I.Q. Loss of the innate cortical engram for action patterns used in skilled reaching and the development of behavioral compensation following motor cortex lesions in the rat. Neuropharmacology 39 (2000) 788-805
182. Whishaw I.Q., Pellis S.M., Gorny B.P., and Pellis V.C. The impairments in reaching and the movements of compensation in rats with motor cortex lesions: an endpoint, videorecording, and movement notation analysis. Behavioural Brain Research 42 (1991) 77-91
183. Wigstrom H., and Gustafsson B. Facilitation of hippocampal long-lasting potentiation by GABA antagonists. Acta Physiologica Scandinavica 125 (1985) 159-172
184. Wilkinson D., Doody R., Helme R., Taubman K., Mintzer J., Kertesz A., and Pratt R.D. Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology 61 (2003) 479-486
185. Wilson M.S., Gibson C.J., and Hamm R.J. Haloperidol, but not olanzapine, impairs cognitive performance after traumatic brain injury in rats. American Journal of Physical Medicine and Rehabilitation 82 (2003) 871-879
186. Windle V., and Corbett D. Fluoxetine and recovery of motor function after focal ischemia in rats. Brain Research 1044 (2005) 25-32
187. Woodlee M.T., and Schallert T. The impact of motor activity and inactivity on the brain: implications for the prevention and treatment of nervous system disorders. Current Directions in Psychological Science 15 (2006) 203-206
188. Wooltorton E. Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials. CMAJ 167 (2002) 1269-1270
189. Wooltorton E. Olanzapine (Zyprexa): increased incidence of cerebrovascular events in dementia trials. CMAJ 170 (2004) 1395
190. Yau J.L., Noble J., Hibberd C., Rowe W.B., Meaney M.J., Morris R.G., and Seckl J.R. Chronic treatment with the antidepressant amitriptyline prevents impairments in water maze learning in aging rats. Journal of Neuroscience 22 (2002) 1436-1442
191. Zhang L., Zhang R.L., Wang Y., Zhang C., Zhang Z.G., Meng H., and Chopp M. Functional recovery in aged and young rats after embolic stroke: treatment with a phosphodiesterase type 5 inhibitor. Stroke 36 (2005) 847-852
192. Zhang R.L., Zhang Z.G., and Chopp M. Neurogenesis in the adult ischemic brain: generation, migration, survival, and restorative therapy. Neuroscientist 11 (2005) 408-416
193. Zhao C.S., Puurunen K., Schallert T., Sivenius J., and Jolkkonen J. Behavioral and histological effects of chronic antipsychotic and antidepressant drug treatment in aged rats with focal ischemic brain injury. Behavioral Brain Research 158 (2005) 211-220
194. Zhao C.S., Puurunen K., Schallert T., Sivenius J., and Jolkkonen J. Behavioral effects of photothrombotic ischemic cortical injury in aged rats treated with the sedative-hypnotic GABAergic drug zopiclone. Behavioral Brain Research 160 (2005) 260-266
195. Zhao C.S., Puurunen K., Schallert T., Sivenius J., and Jolkkonen J. Effect of cholinergic medication, before and after focal photothrombotic ischemic cortical injury, on histological and functional outcome in aged and young adult rats. Behavioral Brain Research 156 (2005) 85-94
196. Ziemann U., Hallett M., and Cohen L.G. Mechanisms of deafferentation-induced plasticity in human motor cortex. Journal of Neuroscience 18 (1998) 7000-7007
197. Zorowitz R.D., Smout R.J., Gassaway J.A., and Horn S.D. Neurostimulant medication usage during stroke rehabilitation: the Post-Stroke Rehabilitation Outcomes Project (PSROP). Topics on Stroke and Rehabilitation 12 (2005) 28-36